Skip to main content
. 2020 Nov 20;12(11):3463. doi: 10.3390/cancers12113463

Table 1.

Clinical profiles of 100 gastric cancer patients with low or high Tid1 expression in tumors.

Characteristic Tid1 Low Expression (0,1) (n = 30) Tid1 High Expression (2,3) (n = 70) p
Age (mean ± SD) 67.80 ± 12.0 67.49 ± 12.6 0.908
Gender
Male 22 57
Female 8 13 0.362
Tumor size
<4 cm 5 19
4–8 cm 17 38
>8 cm 8 13 0.441
Tumor location
Upper stomach 5 15
Middle stomach 15 25
Lower stomach 10 27
Whole stomach 0 3 0.548
Cell grade
Poor differentiated 18 35
Moderate differentiated 11 34
Well differentiated 1 1 0.381
Gross appearance
Superficial type 1 0
Borrmann type I & II 7 25
Borrmann type III & IV 22 45 0.177
Stromal reaction type
Medullary type 2 4
Intermediate type 15 51
Scirrhous type 13 15 0.058
Lauren’s histology
Intestinal type 8 27
Diffuse type 14 19
Mixed type 8 24 0.161
Ming’s histology
Expanding 2 7
Infiltrating 28 63 0.720
Lymphovascular invasion
No 8 19
Yes 22 51 0.133
TNM pathological T category
T1 10 35
T2 7 15
T3 11 14
T4 2 6 0.289
TNM pathological N category
N0 4 19
N1 5 20
N2 7 17
N3 14 14 0.041 *
TNM Stage
I 1 9
II 6 18
III 23 43 0.274
Overall survival rate (5 years) 43.3% 58.5% 0.082
Disease-free survival rate (5 years) 36.7% 57.1% 0.008 *

*, p < 0.05, statistical significance. #, American Joint Committee on Cancer (AJCC) Cancer Staging Manual, eighth edition, T category: T1, T2, T3, T4; N category: N0, N1, N2, N3.